Phentermine Hydrochloride Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-01-07　·　151 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 609.8 Mn
2033 年預估規模: USD 992.1 Mn
年複合成長率 CAGR: 7.2%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-01-07頁數 151報告編號 CMI9186

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Phentermine Hydrochloride Market, By Type (Immediate-Release (IR) Tablets, Extended-Release (ER) Tablets, Capsules, and Oral Solution), By Application (Obesity Treatment, Weight Loss Management, Appetite Suppressant, and Adjunct Therapy for Obesity-Related Conditions), By Drug Type (Prescription Drugs and Over-the-Counter (OTC) Drugs), By Product Type (Brand and Generic), By Age Group (Adult, Pediatric, and Geriatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

According to Coherent Market Insights, the Global Phentermine Hydrochloride Market is estimated to be valued at USD 609.8 Mn in 2026 and is expected to reach USD 992.1 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2026 to 2033. The global phentermine hydrochloride market represents a critical segment within the pharmaceutical industry, focusing on one of the most widely prescribed appetite suppressant medications for obesity management. Phentermine hydrochloride, a sympathomimetic amine, functions as an anorectic agent that stimulates the central nervous system to reduce appetite and promote weight loss in conjunction with diet and exercise programs. This market encompasses various formulations including immediate-release tablets, extended-release capsules, and orally disintegrating tablets, serving healthcare providers and patients worldwide in addressing the growing obesity epidemic. The market's significance has intensified due to rising obesity rates globally, increasing awareness about weight-related health complications, and the growing demand for effective pharmacological interventions for weight management. Key market participants include pharmaceutical manufacturers, generic drug producers, healthcare providers, and regulatory bodies that collectively shape market dynamics through product development, clinical research, regulatory approvals, and distribution strategies. The market operates within a highly regulated environment, requiring stringent safety protocols and efficacy demonstrations, while addressing diverse patient populations across different geographical regions with varying healthcare infrastructures and obesity prevalence rates. Market Dynamics The global phentermine hydrochloride market is primarily driven by the escalating global obesity crisis, with over 650 Mn adults classified as obese worldwide, creating substantial demand for effective weight management pharmaceuticals. Increasing sedentary lifestyles, dietary changes, and genetic predispositions contribute to rising obesity rates, compelling healthcare systems to seek pharmacological solutions like phentermine hydrochloride. Growing awareness among healthcare professionals and patients about the health risks associated with obesity, including diabetes, cardiovascular diseases, and metabolic disorders, further propels market growth. Additionally, expanding healthcare infrastructure in emerging economies, increasing healthcare expenditure, and growing medical insurance coverage enhance market accessibility. However, the market faces significant restraints including stringent regulatory frameworks governing controlled substances, potential side effects such as cardiovascular complications, dependency risks, and contraindications for patients with certain medical conditions. Limited treatment duration recommendations, typically 12 weeks or less, restrict long-term market potential, while competition from alternative weight management therapies and surgical interventions poses additional challenges. Nevertheless, substantial opportunities exist through ongoing research and development for combination therapies, extended-release formulations, and novel delivery mechanisms that could improve efficacy and safety profiles. The development of personalized medicine approaches, integration of digital health platforms for comprehensive weight management programs, and expansion into underserved markets present lucrative growth avenues. Furthermore, increasing focus on preventive healthcare, rising medical tourism, and potential regulatory approvals for extended treatment durations could significantly expand market opportunities while addressing the global obesity burden more effectively. Key Features of the Study • This report provides in-depth analysis of the global phentermine hydrochloride market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global phentermine hydrochloride market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Chemische Fabrik Berg GmbH, Malladi Drugs & Pharmaceuticals Limited, Moehs Iberica, Tenatra Exports, Biotechnica DWC, Siegfried AG, Cambrex Corporation, Cody Laboratories, Inc., Fagron Group, Gyma Laboratories of America, Letco Medical, Medisca, Olon S.p.A, Sun Pharmaceutical Industries Limited, and Symed Labs. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global phentermine hydrochloride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global phentermine hydrochloride market Market Segmentation • Type Insights (Revenue, USD Mn, 2021 - 2033) o Immediate-Release (IR) Tablets o Extended-Release (ER) Tablets o Capsules o Oral Solution • Application Insights (Revenue, USD Mn, 2021 - 2033) o Obesity Treatment o Weight Loss Management o Appetite Suppressant o Adjunct Therapy for Obesity-Related Conditions • Drug Type Insights (Revenue, USD Mn, 2021 - 2033) o Prescription Drugs o Over-the-Counter (OTC) Drugs • Product Type Insights (Revenue, USD Mn, 2021 - 2033) o Brand o Generic • Age Group Insights (Revenue, USD Mn, 2021 - 2033) o Adult o Pediatric o Geriatric • Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033) o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies • Regional Insights (Revenue, USD Mn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Chemische Fabrik Berg GmbH o Malladi Drugs & Pharmaceuticals Limited o Moehs Iberica o Tenatra Exports o Biotechnica DWC o Siegfried AG o Cambrex Corporation o Cody Laboratories, Inc. o Fagron Group o Gyma Laboratories of America o Letco Medical o Medisca o Olon S.p.A o Sun Pharmaceutical Industries Limited o Symed Labs

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Phentermine Hydrochloride Market, By Type  Global Phentermine Hydrochloride Market, By Application  Global Phentermine Hydrochloride Market, By Drug Type  Global Phentermine Hydrochloride Market, By Product Type  Global Phentermine Hydrochloride Market, By Age Group  Global Phentermine Hydrochloride Market, By Distribution Channel  Global Phentermine Hydrochloride Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Driver o Restraint o Opportunity o Impact Analysis o Key Developments o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Merger and Acquisition Scenario o Industry Trends 4. Global Phentermine Hydrochloride Market, By Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Immediate-Release (IR) Tablets  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Extended-Release (ER) Tablets  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Capsules  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Oral Solution  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 5. Global Phentermine Hydrochloride Market, By Application, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Obesity Treatment  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Weight Loss Management  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Appetite Suppressant  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Adjunct Therapy for Obesity-Related Conditions  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 6. Global Phentermine Hydrochloride Market, By Drug Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Prescription Drugs  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Over-the-Counter (OTC) Drugs  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 7. Global Phentermine Hydrochloride Market, By Product Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Brand  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Generic  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 8. Global Phentermine Hydrochloride Market, By Age Group, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Adult  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Pediatric  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Geriatric  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 9. Global Phentermine Hydrochloride Market, By Distribution Channel, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hospital Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Retail Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Online Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 10. Global Phentermine Hydrochloride Market, By Region, 2021 - 2033, Value (USD Mn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn) o South Africa o North Africa o Central Africa 11. Competitive Landscape o Chemische Fabrik Berg GmbH  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Malladi Drugs & Pharmaceuticals Limited  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Moehs Iberica  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Tenatra Exports  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Biotechnica DWC  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Siegfried AG  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Cambrex Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Cody Laboratories, Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Fagron Group  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Gyma Laboratories of America  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Letco Medical  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Medisca  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Olon S.p.A  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Sun Pharmaceutical Industries Limited  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Symed Labs  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 12. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 13. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on 'Phentermine Hydrochloride Market' - Global forecast to 2033

提及公司

Chemische Fabrik Berg GmbHMalladi Drugs & Pharmaceuticals LimitedMoehs IbericaTenatra ExportsBiotechnica DWCSiegfried AGCambrex CorporationCody Laboratories, Inc.Fagron GroupGyma Laboratories of AmericaLetco MedicalMediscaOlon S.p.ASun Pharmaceutical Industries LimitedSymed Labs

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們